Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy



Status:Completed
Conditions:Cancer, Cancer, Endocrine, Thyroid Cancer
Therapuetic Areas:Endocrinology, Oncology
Healthy:No
Age Range:18 - Any
Updated:12/21/2018
Start Date:December 2004
End Date:April 2014

Use our guide to learn which trials are right for you!

A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma

This phase II trial is studying how well bortezomib works in treating patients with
metastatic thyroid cancer that did not respond to radioactive iodine therapy. Bortezomib may
stop the growth of tumor cells by blocking some of the enzymes needed for cell growth

PRIMARY OBJECTIVE:

I. Determine the efficacy of bortezomib, in terms of tumor response rate, in patients with
metastatic papillary or follicular thyroid cancer unresponsive to prior radioiodine therapy.

SECONDARY OBJECTIVE:

I. Determine the clinical activity of this drug, in terms of progression-free survival, in
patients treated with this drug.

OUTLINE: This is an open-label, multicenter study. Patients receive bortezomib IV over 3-5
seconds on days 1, 4, 8, and 11. Treatment repeats every 21 days for at least 4 courses in
the absence of disease progression or unacceptable toxicity. After completion of study
treatment, patients are followed periodically.

Inclusion Criteria:

- The Eastern Cooperative Oncology Group (ECOG) 0-2 OR Karnofsky 60-100%

- Platelet count >= 100,000/mm^3

- Absolute neutrophil count >= 1,500/mm^3

- White Blood Count (WBC) >= 3,000/mm^3

- Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) =< 2.5 times upper
limit of normal

- Bilirubin normal

- No symptomatic congestive heart failure

- Creatinine normal OR creatinine clearance >= 60 mL/min

- No unstable angina pectoris

- No cardiac arrhythmia

- Not pregnant or nursing

- Negative pregnancy test

- Fertile patients must use effective contraception

- No other malignancy within the past 5 years except basal cell skin cancer or carcinoma
in situ of the cervix

- No ongoing or active infection

- No psychiatric illness or social situation that would preclude study compliance

- No other uncontrolled illness

- At least 4 weeks since prior chemotherapy

- No more than 2 prior chemotherapy regimens

- At least 6 months since prior external beam radiotherapy for locoregional disease in
the thyroid bed or to the cervical or upper mediastinal lymph nodes (dose =< 6,000
cGy)

- At least 6 months since prior radioiodine therapy

- No prior external radiotherapy to the measured tumor

- Prior thyroidectomy allowed

- No concurrent combination antiretroviral therapy for HIV-positive patients

- No other concurrent investigational agents

- No other concurrent anticancer therapy

- Unresponsive to prior radioiodine therapy

- Histologically confirmed differentiated thyroid cancer-papillary or follicular type,
including, but not limited to, any of the following variants: hurthle cell
(oxyphilic), insular, columnar cell, tall cell

- Metastatic disease

- At least 1 unidimensionally measurable lesion >= 20 mm by conventional techniques OR
>= 10 mm by spiral CT scan

- No prior radiotherapy to the only measurable lesion

- No radioiodine uptake in the measured metastatic tumor by radioiodine scan (Note: Must
have had >= 1 radioiodine scan since the last radioiodine treatment)

- No known brain metastases
We found this trial at
9
sites
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
201 Dowman Dr
Atlanta, Georgia 30303
(404) 727-6123
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Aurora, CO
Click here to add this to my saved trials
55 Fruit St
Boston, Massachusetts 02114
(617) 724-4000
Massachusetts General Hospital Cancer Center An integral part of one of the world
?
mi
from
Boston, MA
Click here to add this to my saved trials
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
2049 E 100th St
Cleveland, Ohio 44106
(216) 444-2200
Cleveland Clinic Foundation The Cleveland Clinic (formally known as The Cleveland Clinic Foundation) is a...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
300 W 10th Ave
Columbus, Ohio 43210
(800) 293-5066
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center...
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
3700 O Street Northwest
Washington, District of Columbia 20057
?
mi
from
Washington,
Click here to add this to my saved trials